Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
27
CAPR Quote, Financials, Valuation and Earnings
Last price:
$6.99
Seasonality move
:
38.01%
Day range:
$6.83 - $7.44
52-week range:
$3.52 - $23.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
12.59x
P/B ratio:
2.59x
Volume:
2.1M
Avg. volume:
3.4M
1-year change:
49.59%
Market cap:
$330.9M
Revenue:
$22.3M
EPS (TTM):
-$1.42
Earnings Data
Next earnings date for CAPR
Aug 07
2025
Most recent earnings per share
-$0.53
Missed by $0.21
(May 13/2025)
Consensus Estimate
-$0.32
(May 13/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CAPR Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $640K | -- | -- | -$0.47 | -- |
| 08/07/2025 | Q2 | $778K | -- | -- | -$0.48 | -- |
| 05/13/2025 | Q1 | $3.2M | -- | -$0.53 | -$0.32 | -$0.21 |
| 03/19/2025 | Q4 | $9.9M | $11.1M | -$0.16 | -$0.09 | -$0.07 |
| 11/13/2024 | Q3 | $3.6M | $2.3M | -$0.38 | -$0.34 | -$0.04 |
| 08/07/2024 | Q2 | $3.7M | $4M | -$0.35 | -$0.33 | -$0.02 |
| 05/13/2024 | Q1 | $9.7M | $4.9M | -$0.31 | -$0.11 | -$0.20 |
| 02/29/2024 | Q4 | $8M | $12.1M | $0.02 | -$0.09 | $0.11 |
| 11/14/2023 | Q3 | -- | -- | -$0.25 | -$0.27 | $0.02 |
| 08/07/2023 | Q2 | -- | -- | -$0.29 | -$0.33 | $0.04 |
| 05/11/2023 | Q1 | -- | -- | -$0.31 | -$0.32 | $0.01 |
| 03/15/2023 | Q4 | -- | -- | -$0.31 | -$0.34 | $0.03 |
| 11/10/2022 | Q3 | -- | -- | -$0.26 | -$0.32 | $0.06 |
| 08/10/2022 | Q2 | -- | -- | -$0.29 | -- | -- |
| 05/10/2022 | Q1 | -- | -- | -$0.32 | -- | -- |
| 03/10/2022 | Q4 | -- | -- | -$0.26 | -- | -- |
| 11/09/2021 | Q3 | -- | -- | -$0.17 | -- | -- |
| 08/12/2021 | Q2 | -- | -- | -$0.21 | -- | -- |
| 05/13/2021 | Q1 | -- | -- | -$0.23 | -- | -- |
| 03/11/2021 | Q4 | -- | -- | -$0.21 | -- | -- |
| 11/12/2020 | Q3 | -- | -- | -$0.20 | -- | -- |
| 08/06/2020 | Q2 | -- | -- | -$0.23 | -- | -- |
| 05/14/2020 | Q1 | -- | -- | -$0.30 | -- | -- |
| 03/18/2020 | Q4 | -- | -- | -$0.34 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$0.43 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$0.59 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$0.75 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$1.10 | -- | -- |
| 11/13/2018 | Q3 | -- | -- | -$1.35 | -- | -- |
| 08/09/2018 | Q2 | -- | -- | -$1.42 | -- | -- |
| 05/10/2018 | Q1 | -- | -- | -$1.40 | -- | -- |
| 03/14/2018 | Q4 | -- | -- | $4.20 | -- | -- |
| 11/08/2017 | Q3 | -- | -- | -$1.20 | -- | -- |
| 08/10/2017 | Q2 | -- | -- | -$1.60 | -- | -- |
| 05/15/2017 | Q1 | -- | -- | -$1.70 | -- | -- |
| 03/15/2017 | Q4 | -- | -- | -$2.10 | -- | -- |
| 11/10/2016 | Q3 | -- | -- | -$2.90 | -- | -- |
| 08/15/2016 | Q2 | -- | -- | -$2.60 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$2.60 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$2.10 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -$1.80 | -- | -- |
Capricor Therapeutics Earnings Questions
-
How Much did Capricor Therapeutics Generate in Revenue Last Quarter?
Capricor Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Capricor Therapeutics Beat Earnings Last Quarter?
Capricor Therapeutics announced earnings per share of -$0.53 which represents a miss of analyst forecast a -$0.32 per share.
-
Is Capricor Therapeutics Profitable?
Capricor Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Capricor Therapeutics EPS Next Year?
Capricor Therapeutics's earnings are forecast to decrease from -$1.15 per share to -$1.07 per share next year representing a decrease of -78.78%.
-
When is Capricor Therapeutics's Earnings Date?
Capricor Therapeutics's next earnings date is August 7, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 3.58% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.66% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 8.31% over the past day.
